Incyte (INCY) Receives a Hold from Stifel Nicolaus
In a report released today, Stephen Willey from Stifel Nicolaus maintained a Hold rating on Incyte (INCY – Research Report), with a price ...
Incyte companion study of Opzelura fell short, says Citi
Citi keeps a Buy rating on Incyte (INCY) with an $88 price target after the company presented data from its pivotal Phase 3 TRuE-PN1 trial ...